Another frequent question from patients is, "How long until my psoriasis is gone?" Each biologic is believed to have a different re sponse time and the relative rates of response are listed in ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...

A new study published in the Archives of Dermatological Research found that patients with psoriasis who were receiving ...

Of the three, etanercept clearly gained from its first-to-market advantage and is currently the most widely prescribed biologic for psoriasis. Its annual sales for this indication exceed $1.1 ...

A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...

However, the shelf life after reconstitution varies with the biologic. Efalizumab can be ... Areas with bruising, redness, open sores, or psoriasis plaques should be avoided.

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Biologics often help when other treatments haven’t worked to treat psoriasis. They’re synthetic versions of proteins created from human cells that target specific parts of your immune system.

The biologic therapies sector, distinguished by its targeted action and robust efficacy, holds the crown as the leading ...

Biologics, which appear to have a safer risk-to-benefit ratio compared to cyclosporine, have more or less supplanted this drug for psoriasis in most patients. Humira (adalimumab) is a commonly ...